Johnson & Johnson EV/Sales
Quel est le EV/Sales de Johnson & Johnson?
Le EV/Sales de Johnson & Johnson est 5.93
Quelle est la définition de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales des entreprises dans Health Care secteur sur NYSE par rapport à Johnson & Johnson
Que fait Johnson & Johnson?
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Entreprises avec ev/sales similaire à Johnson & Johnson
- Paramount Inc a EV/Sales de 5.92
- Mcphy S.A. Eo 0,12 a EV/Sales de 5.92
- Crossword Cybersecurity Plc a EV/Sales de 5.92
- iShares € Corp Bond 0-3yr ESG UCITS ETF EUR (Dist) a EV/Sales de 5.93
- Budweiser Brewing APAC a EV/Sales de 5.93
- Vixtel Technologies a EV/Sales de 5.93
- Johnson & Johnson a EV/Sales de 5.93
- ASM International NV a EV/Sales de 5.94
- SiteMinder a EV/Sales de 5.94
- Aon plc a EV/Sales de 5.94
- Atlas a EV/Sales de 5.94
- Housing Development Finance a EV/Sales de 5.94
- Avid Bioservices Inc a EV/Sales de 5.94